BroadOak Logo

Bryan Poltilove Joins BroadOak Capital Partners Team

Bryan PoltiloveBroadOak Capital Partners is pleased to announce the addition of Bryan Poltilove to its growth capital investing team, where he serves as a Managing Director. Mr. Poltilove joins BroadOak from Thermo Fisher Scientific and brings with him significant domain and operational expertise. Most recently as a Vice President at Thermo Fisher, Mr. Poltilove built and led a new business segment to integrate the company’s capabilities in cell and gene therapy. He also served as General Manager for Thermo Fisher’s $200 million Clinical Diagnostic Reagents business. Prior to Thermo Fisher, Mr. Poltilove served as Director of Revenue Strategy & Operations for the Corporate Executive Board and held several commercial strategy roles with Johnson & Johnson. He holds B.S. degrees in Chemical Engineering and Economics from MIT as well as an MBA from Northwestern University’s Kellogg School of Management.

Read the full BioBuzz story announcing Mr. Poltilove’s new role.

View Mr. Poltilove’s bio on